SENTINEL APART

Welcome to the Brand page for “SENTINEL APART”, which is offered here for Product development services for prediction and correction of antibody aggregation; platform as a service (paas) featuring a computer software platform in the field of antibody aggregation risk prediction and re-engineering;.

Its status is currently believed to be active. Its class is unavailable. “SENTINEL APART” is believed to be currently owned by “LONZA LTD.”

Owner:
LONZA LTD.
Owner Details
Description:
Product development services for prediction and correction of antibody aggregation; platform as a service (PAAS) featuring a computer software platform in the field of antibody aggregation risk prediction and re-engineering;
Categories: PRODUCT DEVELOPMENT SERVICES PREDICTION